. 2010 Jul 20;21(12):1471–1477. doi: 10.1007/s00192-010-1214-1

Table 3.

Summary of the 32 reported treatment-related adverse events which occurred after 182 injections

Adverse events	No. of occurrences
UTI	10
Injection site pain	5
Urinary retention	2^a
Voiding difficulties	2^b
Past void residual >100 ml	2^c
Haematuria	2
Urine incontinence aggravated	2
De novo urge incontinence	2
Injection site laceration	1
Headache	4

^aClassified as serious due to hospitalization, recovered within 6 and 9 days, respectively

^bNot catheterized

^cCatheterized 2 and 4 times within 3 days, respectively